The inhibition of apoptosis (by a combination of Z-DEVD, a caspase-3 inhibitor, and everolimus) during radiotherapy resulted in improved radiation cytotoxicity compared with either agent alone in a xenograft model of H460 non-small cell lung cancer cells [33]. Here, CASP3 is linked to non-small cell lung carcinoma.